5 research outputs found

    Cancer in pregnancy: safety and efficacy of systemic therapies

    Get PDF
    Cancer in pregnancy has become increasingly frequent. It has become clear that for specific cancers under well defined circumstances, oncological treatment in pregnancy can be well tolerated and feasible for both mother and fetus. Continued critical assessment of the available literature and registration of cancer in pregnancy cases and outcomes for mother and child are necessary to work toward implementing optimal cancer treatment during pregnancy. Physiologic changes in pregnancy may alter distribution and efficacy of systemic therapy. Data on systemic therapy including, chemotherapy, hormonal therapy, and targeted therapy during pregnancy are available but incomplete. Outcomes of fetuses exposed to chemotherapy in utero are generally reassuring, but new targeted therapies are mostly discouraged in pregnancy. Cancer treatment during pregnancy is possible, depending on type and timing of systemic therapy and treatment modality. Available data are reassuring with a modest increase in complications such as growth restriction and preterm birth. The effect of new targeted therapies is often still unclear and therefore discourage

    Microfossil biostratigraphy data supporting "Lower Jurassic (Hettangian–Pliensbachian) microfossil biostratigraphy of the Ballinlea-1 well, Rathlin Basin, Northern Ireland, United Kingdom"

    No full text
    This the raw count data for Early Jurassic ostracods and foraminifera from Ballinlea-1 Exploration Well. Data originally prepared during PhD study by Azrin Azmi (supervised by Ian Boomer). Selection of slides later examined by Ian Boomer and Phil Copestake. Samples are cuttings. Ostracod counts are for valves, 1 carapace = 2, Adults and juveniles combined. No interpretations made for possible caved specimens. All depths are drill depths below Kelly Bushing
    corecore